| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |